Oak Asset Management, LLC Amgen Inc Transaction History

Oak Asset Management, LLC

$273 Million
Q2 2024

A detailed history of Oak Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Oak Asset Management, LLC holds 63,465 shares of AMGN stock, worth $20.3 Million. This represents 7.27% of its overall portfolio holdings.

Number of Shares

63,465

Previous 63,537 0.11%

Holding current value

$20.3 Million

Previous $18.1 Million 9.77%

% of portfolio

7.27%

Previous 6.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $18,918 - $22,990	-72 Reduced 0.11%	63,465 $19.8 Million
Q1 2024 Apr 17, 2024	SELL	$268.87 - $324.56 $43,556 - $52,578	-162 Reduced 0.25%	63,537 $18.1 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $55,231 - $62,307	216 Added 0.34%	63,699 $18.3 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $2,405 - $2,986	-11 Reduced 0.02%	63,483 $17.1 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $112,063 - $132,512	523 Added 0.83%	63,494 $14.1 Million
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $129,151 - $157,414	572 Added 0.92%	62,971 $15.2 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $338,277 - $429,821	-1,477 Reduced 2.31%	62,399 $16.4 Million
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $14.3 Million - $16.2 Million	63,876 New	63,876 $14.4 Million
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $14.7 Million - $16.4 Million	-63,890 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $145,376 - $160,823	-663 Reduced 1.03%	63,890 $15.5 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $10,938 - $12,518	-55 Reduced 0.09%	64,553 $14.5 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $704,736 - $825,684	3,320 Added 5.42%	64,608 $13.1 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $368,122 - $408,404	1,576 Added 2.64%	61,288 $14.9 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $40,609 - $47,323	183 Added 0.31%	59,712 $14.9 Million
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $62,750 - $74,724	290 Added 0.49%	59,529 $13.7 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $370,043 - $411,518	-1,577 Reduced 2.59%	59,239 $13.5 Million
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $115,521 - $141,760	-584 Reduced 0.95%	60,816 $14.3 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $155,632 - $206,411	-854 Reduced 1.37%	61,400 $12.4 Million
Q4 2019 Jan 09, 2020	SELL	$189.21 - $243.2 $306,709 - $394,227	-1,621 Reduced 2.54%	62,254 $15 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $189,431 - $226,978	-1,088 Reduced 1.67%	63,875 $12.4 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $338,401 - $396,682	2,030 Added 3.23%	64,963 $11.4 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $1.53 Million - $1.72 Million	8,449 Added 15.51%	62,933 $12 Million
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $695,224 - $811,550	3,897 Added 7.7%	54,484 $10.6 Million
Q3 2018 Oct 22, 2018	BUY	$185.29 - $208.89 $354,089 - $399,188	1,911 Added 3.93%	50,587 $10.5 Million
Q2 2018 Aug 01, 2018	BUY	$166.05 - $186.51 $1.19 Million - $1.33 Million	7,142 Added 17.2%	48,676 $8.99 Million
Q1 2018 Apr 23, 2018	SELL	$169.43 - $198.0 $27,278 - $31,878	-161 Reduced 0.39%	41,534 $7.08 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $7.04 Million - $7.86 Million	41,695	41,695 $7.25 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Asset Management, LLC with notifications on news.

Account

Oak Asset Management, LLC Amgen Inc Transaction History